The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Tilray Brands's Revenue for the
three
months ended in Feb. 2026 was C$282 Mil. Tilray Brands's average Accounts Receivable for the
three
months ended in Feb. 2026 was C$157 Mil.
Hence, Tilray Brands's Receivables Turnover for the
three
months ended in Feb. 2026 was 1.79.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Tilray Brands Receivables Turnover Related Terms
Tilray Brands Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Tilray Brands's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSX:TLRY vs AQST, EOLS, NIKA: Receivables Turnover Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Tilray Brands's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tilray Brands Receivables Turnover vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Tilray Brands's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Tilray Brands's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tilray Brands (TSX:TLRY) has a Receivables Turnover of 1.79 as of Feb. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Tilray Brands and its competitors. According to the industry distribution chart, Tilray Brands ranks #229 out of 947 companies in the Drug Manufacturers industry, placing it in the top 24.2%.
Is Tilray Brands' Receivables Turnover too high?
Tilray Brands' current Receivables Turnover is 1.79. The Drug Manufacturers industry median Receivables Turnover is 5.07. Tilray Brands' value of 1.79 is 64.7% below this industry median. Based on the distribution chart, Tilray Brands ranks #229 out of 947 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Tilray Brands has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Tilray Brands' Receivables Turnover compare to AQST and EOLS?
According to the Drug Manufacturers industry distribution chart, Tilray Brands ranks #229 out of 947 companies for Receivables Turnover. This places Tilray Brands in the top 24% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 5.07. Tilray Brands' value of 1.79 is 64.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Drug Manufacturers company?
The median Receivables Turnover among Drug Manufacturers companies is 5.07, based on 947 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tilray Brands's current Receivables Turnover of 1.79 is 64.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Tilray Brands and its competitors. For the Drug Manufacturers industry, the median Receivables Turnover is 5.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tilray Brands's current Receivables Turnover is 1.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tilray Brands stock overvalued right now?
Based on GuruFocus' analysis, Tilray Brands (TSX:TLRY) is currently considered Possible Value Trap. The stock's GF Value™ is C$17.38, compared to a current price of C$6.23 — trading 64.2% below its estimated fair value. The current Receivables Turnover is 1.79 and 64.7% below the Drug Manufacturers industry median of 5.07. Tilray Brands' overall GF Score™ is 59/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Tilray Brands (TSX:TLRY), the current Receivables Turnover is 1.79 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tilray Brands (TSX:TLRY) Overvalued in 2026?
Based on GuruFocus' analysis, Tilray Brands stock appears to be undervalued.
The current stock price of C$6.23 is trading 64.2% below its estimated GF Value™ of C$17.38.
GuruFocus considers Tilray Brands to be Possible Value Trap.
Key valuation signals for TSX:TLRY:
Receivables Turnover: 1.79
GF Value™: C$17.38 vs. price of C$6.23 (64.2% below fair value)
Industry Position: 64.7% below the Drug Manufacturers median (#229 of 947)
No single metric tells the full story. See the TSX:TLRY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.
59GF Score
Get the complete analysis for TSX:TLRY
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSX:TLRY has been successfully added to your 
